Executives at privately-held Indian firm Centaur Pharmaceuticals Pvt. Ltd. have confirmed to Scrip that a planned alliance for the Indian market with mid-sized Japanese ophthalmic care company Santen Pharmaceutical Co. Ltd., first discussed less than two years ago, will not now be going ahead.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?